The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells
- Author
- KONDO, Eisei1 ; MAECKER, Britta2 ; DRAUBE, Andreas1 ; KLEIN-GONZALEZ, Nela1 ; SHIMABUKURO-VORNHAGEN, Alexander1 3 ; SCHULTZE, Joachim L4 ; VON BERGWELT-BAILDON, Michael S1 3
[1] Max Eder Junior Research Group, Clinic I for Internal Medicine, University Hospital of Cologne, Cologne, Germany
[2] Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany
[3] Stem Cell Transplantation Program, Clinic I for Internal Medicine, University Hospital of Cologne, Cologne, Germany
[4] Laboratory for Genomics and Immunoregulation, Program Unit Molecular Immune and Cell Biology, Life and Medical Sciences Bonn, University of Bonn, Bonn, Germany - Source
International journal of cancer (Print). = Journal international du cancer. 2009, Vol 125, Num 10, pp 2474-2478, 5 p ; ref : 36 ref
- CODEN
- IJCNAW
- ISSN
- 0020-7136
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Blackwell, Hoboken, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- CTL cyclin-A2 immunotherapy tumor antigen tumor
- Keyword (fr)
- Anticancéreux Antigène associé tumeur Cancérologie Cycline A2 Homme Immunothérapie Lymphocyte T cytotoxique Réponse immune Traitement Tumeur maligne Cancer
- Keyword (en)
- Antineoplastic agent Tumor associated antigen Cancerology Cyclin A2 Human Immunotherapy Cytotoxic T lymphocyte Immune response Treatment Malignant tumor Cancer
- Keyword (es)
- Anticanceroso Antígeno asociado tumor Cancerología Ciclina A2 Hombre Inmunoterapia Linfocito T citotóxico Respuesta inmune Tratamiento Tumor maligno Cáncer
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R03 Immunotherapy
- Discipline
- Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22002163
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/ijc.24629 
https://dx.doi.org/10.1002/ijc.24629
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.24629\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"125\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2474\";s:8:\"\u0000*\u0000epage\";s:4:\"2478\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KONDO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Eisei\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"MAECKER, Britta\";i:1;s:15:\"DRAUBE, Andreas\";i:2;s:20:\"KLEIN-GONZALEZ, Nela\";i:3;s:32:\"SHIMABUKURO-VORNHAGEN, Alexander\";i:4;s:19:\"SCHULTZE, Joachim L\";i:5;s:31:\"VON BERGWELT-BAILDON, Michael S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.24629\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"125\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2474\";s:8:\"\u0000*\u0000epage\";s:4:\"2478\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KONDO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Eisei\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"MAECKER, Britta\";i:1;s:15:\"DRAUBE, Andreas\";i:2;s:20:\"KLEIN-GONZALEZ, Nela\";i:3;s:32:\"SHIMABUKURO-VORNHAGEN, Alexander\";i:4;s:19:\"SCHULTZE, Joachim L\";i:5;s:31:\"VON BERGWELT-BAILDON, Michael S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.24629\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.24629\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"125\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2474\";s:8:\"\u0000*\u0000epage\";s:4:\"2478\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KONDO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Eisei\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"MAECKER, Britta\";i:1;s:15:\"DRAUBE, Andreas\";i:2;s:20:\"KLEIN-GONZALEZ, Nela\";i:3;s:32:\"SHIMABUKURO-VORNHAGEN, Alexander\";i:4;s:19:\"SCHULTZE, Joachim L\";i:5;s:31:\"VON BERGWELT-BAILDON, Michael S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.24629\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"125\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2474\";s:8:\"\u0000*\u0000epage\";s:4:\"2478\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KONDO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Eisei\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"MAECKER, Britta\";i:1;s:15:\"DRAUBE, Andreas\";i:2;s:20:\"KLEIN-GONZALEZ, Nela\";i:3;s:32:\"SHIMABUKURO-VORNHAGEN, Alexander\";i:4;s:19:\"SCHULTZE, Joachim L\";i:5;s:31:\"VON BERGWELT-BAILDON, Michael S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/ijc.24629\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:9:\"\u0000*\u0000jtitle\";s:39:\"International journal of cancer (Print)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Int. j. cancer (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"125\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2474\";s:8:\"\u0000*\u0000epage\";s:4:\"2478\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0020-7136\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KONDO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Eisei\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:15:\"MAECKER, Britta\";i:1;s:15:\"DRAUBE, Andreas\";i:2;s:20:\"KLEIN-GONZALEZ, Nela\";i:3;s:32:\"SHIMABUKURO-VORNHAGEN, Alexander\";i:4;s:19:\"SCHULTZE, Joachim L\";i:5;s:31:\"VON BERGWELT-BAILDON, Michael S\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"IJCNAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
